| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10012438 | HBV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS10048201 | HBV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS10057697 | HBV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS30081745 | HIV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS30025999 | HIV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS30026000 | HIV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS20000512 | HPV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS20047455 | HPV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS20040280 | HPV | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
| TVIS44033384 | HTLV-1 | ENSG00000116711.10 | protein_coding | PLA2G4A | No | No | 5321 | P47712 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PLA2G4A |
|---|---|
| DrugBank ID | DB06311 |
| Drug Name | Darapladib |
| Target ID | BE0000657 |
| UniProt ID | P47712 |
| Regulation Type | |
| PubMed IDs | 19790016 |
| Citations | Riley RF, Corson MA: Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease. IDrugs. 2009 Oct;12(10):648-55. |
| Groups | Investigational |
| Direct Classification | Biphenyls and derivatives |
| SMILES | CCN(CC)CCN(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C2=C(CCC2)C(=O)N=C1SCC1=CC=C(F)C=C1 |
| Pathways | |
| PharmGKB | PA165884699 |
| ChEMBL | CHEMBL204021 |
